Conference image

Best of Hematology and Breast Cancer™ 2026, Nashville

(7.25 Credits)

location-icon

Sheraton Grand Nashville Downtown

623 Union St, Nashville, TN, United States

calendar-icon

February 6 - February 7, 2026

Conference Summary:

Events StartsEvents Ends
February 6, 2026February 7, 2026

Organizing Committee:

Target Audience:

Learning Objectives:

Agenda

Day 1: Friday, February 6th, 2026

All timings are in Central Time (CDT, GMT-05:00) time.

02:30 PM - 03:30 PMRegistration, Networking, & Exhibits ( Ballroom Foyer & Ballroom 2/3 )

03:30 PM - 05:00 PMSession 1: Benign Hematology (Ballroom 4)

Session Chair:

Michelle Chi, MD

03:30 PM - 04:00 PM

Clotting Disorders

- Deva Sharma, MD

04:00 PM - 04:15 PM

Bleeding Disorders

- Michelle Chi, MD

04:15 PM - 04:45 PM

Updates in the management of Anemia

- Katherine Walsh, MD

04:45 PM - 05:00 PM

Updates in PNH / HUS / TTP

- Miriam Brown, DO

Day 2: Saturday, February 7th, 2026

07:00 AM - 08:00 AMRegistration, Exhibits & Breakfast ( Ballroom Foyer & Ballroom 2/3 )

08:00 AM - 08:05 AMWelcome (Ballroom 4)

08:05 AM - 08:30 AMBinaytara's Efforts in Improving Cancer Care Disparities

Conference Chair:

Justin Ryan Marquart, MBA

08:30 AM - 09:30 AMSession 2: AML/MDS ( Ballroom 4)

Session Chair:

Kateryna Fedorov, MD

08:30 AM - 09:00 AM

Menin inhibitors in acute Leukemias

- Kateryna Fedorov, MD

09:00 AM - 09:30 AM

MDS/MPN Updates 2025

- Ashwin Kishtagari, MD

09:30 AM - 10:45 AMSession 3: Multiple Myeloma ( Ballroom 4 )

Session Chair:

Muhamed Baljevic, MD

09:30 AM - 09:55 AM

Updates in TE and TIE NDMM

- Phyu Naing, MD

09:55 AM - 10:20 AM

Treatment approaches in early RRMM

- Noura Elsedawy, MD

10:20 AM - 10:45 AM

Treatment approaches in late RRMM

- Salyka Sengsayadeth, MD

10:45 AM - 11:00 AMBreak & Exhibits (Ballroom 2/3)

11:00 AM - 12:00 PMSession 4: Lymphoma ( Ballroom 4)

Session Chair:

Vivek Patel, MD

11:00 AM - 11:30 AM

Updates in the management of High-grade and large cell lymphomas

- Elisa De Togni, MD

11:30 AM - 12:00 PM

Updates in the management of indolent Lymphomas

- Vivek Patel, MD

12:00 PM - 01:00 PMLunch & Exhibits - Product Theater sponsored by Kura (non-CME accredited): Managing KOMZIFTI in Patients With R/R NPM1-m AML - Dr. James McCloskey ( Ryman Meeting Room)

01:00 PM - 02:20 PMSession 5: Metastatic Breast Cancer ( Ballroom 4)

Session Chair:

Erika Hamilton, MD

01:00 PM - 01:20 PM

Novel Backbones and Combinations in Metastatic HR+ Breast

- Sarah Premji, MD

01:20 PM - 01:40 PM

Debate: DB-09 vs. DB-03 for HER-2+ Breast

- Sonya Reid, MD

01:40 PM - 02:00 PM

Debate 2: DB-09 vs. DB-03 for HER-2+ Breast

- Gregory Vidal, MD, PhD

02:00 PM - 02:20 PM

Novel ADCs for metastatic HR+ and TNBC

- Erika Hamilton, MD

02:20 PM - 02:30 PMBreak & Exhibits ( Ballroom 4)

02:30 PM - 03:50 PMSession 6: Early Breast Cancer ( Ballroom 4)

Session Chair:

Kelsey Martin, ARNP

02:30 PM - 02:50 PM

Early HR+ Risk Estimation and Treatment

- Kelly Elizabeth McCann, MD, PhD

02:50 PM - 03:10 PM

Where do we stand with early TNBC?

- Sara Nunnery, MD

03:10 PM - 03:30 PM

Early HER-2+ Breast Cancer

- Samyukta Mullangi, MD, MBA

03:30 PM - 03:50 PM

Toxicity Challenges: ADCs and PIK3/mTOR/AKT

- Kelsey Martin, ARNP

03:50 PM - 03:55 PMAdjourn

Conference Chair

MB

Muhamed Baljevic, MD

Vanderbilt University Medical Center

EH

Erika Hamilton, MD

-

Session Chair

KM

Kelsey Martin, ARNP

-

VP

Vivek Patel, MD

Vanderbilt University Medical Center

EH

Erika Hamilton, MD

-

KF

Kateryna Fedorov, MD

-

MB

Muhamed Baljevic, MD

Vanderbilt University Medical Center

MC

Michelle Chi, MD

-

Faculty

SM

Samyukta Mullangi, MD, MBA

-

AK

Ashwin Kishtagari, MD

Vanderbilt University Medical Center

GV

Gregory Vidal, MD, PhD

-

Sarah Premji

Sarah Premji, MD

Sarah Cannon Research Institute

SN

Sara Nunnery, MD

-

SR

Sonya Reid, MD

Vanderbilt

KW

Katherine Walsh, MD

-

KM

Kelly Elizabeth McCann, MD, PhD

University of California Los Angeles

SS

Salyka Sengsayadeth, MD

Vanderbilt University Medical Center

NE

Noura Elsedawy, MD

University of Tennessee Health Science Center

DS

Deva Sharma, MD

-

PN

Phyu Naing, MD

-

MB

Miriam Brown, DO

-

ED

Elisa De Togni, MD

-

Staff

NB

Nafiso Bakar, n/a

Binaytara

Binay Shah

Binay Shah, MBBS

-

TS

Tara Shah, BSN

Binaytara

AK

Audrey Kerby

-

JM

Justin Ryan Marquart, MBA

Binaytara

BS

Bhawana Srivastava, MBA

Binayatara

Acknowledgement of Commerical Support

This activity is supported with Independent Medical Education grants from:

  • Gilead
  • Stemline Therapeutics, Inc

Accreditation

Exhibit & Sponsorship Information

If you are interested in exhibiting at this meeting or if your company is already exhibiting and informed you of a discounted badge rate, please visit our Exhibit Page for those details.